Regulatory oversight of behavioral digital therapeutics for addiction treatment: A commentary on Khadjesari et al.

Commentary
par
Vilardaga, Roger, and F. Joseph McClernon

Date de publication

2021

Géographie

USA

Langue de la ressource

English

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Non

Évalué par des pairs

No

Constatations/points à retenir

As noted by Khadjesari et al., digital therapeutics have the promise to reduce the treatment reach gap -- or at least mitigate this shortage by supplying additional means of help. However, making digital therapeutics widely available does not guarantee that they will have an equitable public health impact. For instance, the ‘digital divide’ is a new social determinant of health [3] that may increase health inequities among vulnerable patient populations

Mots clés

Policy/Regulatory
Digital health